Processa Pharmaceuticals, Inc. - Common Stock (PCSA)
0.2940
-0.0460 (-13.53%)
NASDAQ · Last Trade: Apr 8th, 3:29 AM EDT
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · April 3, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via Chartmill · April 3, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025

Processa Pharma just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024
Via Benzinga · April 2, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · April 2, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · January 30, 2025

Via Benzinga · January 30, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · January 29, 2025

Via Benzinga · December 11, 2024

Via Benzinga · December 10, 2024

Via Benzinga · November 6, 2024

Via Benzinga · October 10, 2024

Via Benzinga · October 3, 2024

Via Benzinga · October 2, 2024

PCSA stock results show that Processa Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024

Via Benzinga · July 30, 2024

Via Benzinga · July 30, 2024

2U stock is up on Tuesday with heavy trading of TWOU shares as they continue to rally following a bankruptcy filing.
Via InvestorPlace · July 30, 2024

Processa Pharmaceuticals stock is up on Tuesday as PCSA investors react to approval for a Phase 2 clinical trial of NGC-Cap.
Via InvestorPlace · July 30, 2024